Mr. Tom Eisiminger, Jr. has been unanimously elected as President and Chief Executive Officer (CEO) at Regenesis Biomedical, Inc. by their Board of Directors.
Tom Eisiminger has been with Regenesis Biomedical for 14 years leading the sales efforts. Tom served in successive leadership roles culminating in his most recent position as Vice President of Sales. Tom served our country for 20+ years and is a decorated combat veteran. Tom is a member of the Veterans of Foreign Wars, the American Legion, and the Disabled American Veterans. He is a veteran’s advocate and serves as President of the Veterans Medical Leadership Council (VMLC) and is a member of the Arizona Veterans Hall of Fame. He currently serves on the Board of Directors of the American Diabetes Association (ADA) – Arizona, New Mexico, and Utah chapter.
“I look forward to leading Regenesis towards accelerated growth with our team of dedicated colleagues,” says CEO Tom Eisiminger. “To accomplish growth and market expansion, we will focus on these key value drivers: Clinical evidence, new FDA-cleared indications, intellectual property, and product development. I am pleased that the current senior management team will continue in the new leadership structure.”